The 20‐HETE/GPR75 Axis Drives NLRP1 Inflammasome Activation via p53 in Bronchopulmonary Dysplasia
Advanced Biology · 2026-07 · 10 (7)
DOI: 10.1002/adbi.202500321 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Biology, online erschienen am 23.07.2026. Verfasst von QiuXiang Xu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, Shanxi Children's Hospital, Taiyuan, Shanxi, China. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, Inflammasomes, Bronchopulmonary Dysplasia, Hydroxyeicosatetraenoic Acids. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Shenyang Children's Hospital.
Abstract (Originalsprache)
Bronchopulmonary dysplasia (BPD), a debilitating chronic respiratory condition afflicting preterm neonates, stems from oxidative injury and is characterized by arrested alveolar growth and aberrant inflammatory responses. This investigation uncovers a novel mechanistic axis in which the 20‐hydroxyeicosatetraenoic acid (20‐HETE)/GPR75 signaling cascade acts as a previously unrecognized driver of NLRP1 inflammasome activation in neonatal BPD, thereby linking oxidative stress to inflammatory signaling via p53. Using murine hyperoxia models, we observe that excessive oxygen exposure selectively upregulates GPR75 expression and 20‐HETE biosynthesis within alveolar epithelial cells. Genetic inactivation of Gpr75 in vivo significantly attenuated hyperoxia‐induced lung injury, oxidative stress, and NLRP1‐dependent secretion of interleukin‐1β and interleukin‐18. Mechanistic dissection revealed that 20‐HETE induces NLRP1 inflammasome assembly in rat alveolar epithelia via p53‐mediated signaling. In vitro corroboration via lentiviral‐mediated Gpr75 silencing, with scrambled shRNA serving as a negative control, further validated its role in hyperoxia‐triggered NLRP1 activation and cytokine release (P < 0.01 vs. scrambled control). Collectively, these findings establish the 20‐HETE/GPR75 axis as a critical regulator of inflammasome‐dependent pathogenesis in BPD. Blockade of this axis inhibits inflammasome assembly and downstream inflammation by suppressing p53 signaling. These results highlight this axis as a promising therapeutic target to mitigate oxygen‐induced injury and inflammatory sequelae in preterm infants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Emergency Medicine, Shanxi Children's Hospital, Taiyuan, Shanxi, China.
- Department of Medicine, Shenyang Children's Hospital, Shenyang, China.
- Department of Pediatrics, Shenyang Children's Hospital, Shenyang, China.
ORCID-Profile: Jian Kang
Förderung
- Shenyang Children's Hospital
Zitieren
APA
Xu, Q., Tian, X., Li, B., & Kang, J. (2026). The 20‐HETE/GPR75 Axis Drives NLRP1 Inflammasome Activation via p53 in Bronchopulmonary Dysplasia. Advanced Biology, 10(7). https://doi.org/10.1002/adbi.202500321
Vancouver
Xu Q, Tian X, Li B, Kang J. The 20‐HETE/GPR75 Axis Drives NLRP1 Inflammasome Activation via p53 in Bronchopulmonary Dysplasia. Advanced Biology. 2026;10(7). doi:10.1002/adbi.202500321
BibTeX
@article{Xu2026,
author = {Xu, QiuXiang and Tian, XiaoLi and Li, Bin and Kang, Jian},
title = {The 20‐HETE/GPR75 Axis Drives NLRP1 Inflammasome Activation via p53 in Bronchopulmonary Dysplasia},
journal = {Advanced Biology},
year = {2026},
volume = {10},
number = {7},
doi = {10.1002/adbi.202500321}
}
EUVIMED